✦ LIBER ✦

Tissue plasminogen activator was cost-effective compared to streptokinase in only selected patients with acute myocardial infarction

✍ Scribed by David M. Kent; Sandeep Vijan; Rodney A. Hayward; John L. Griffith; Joni R. Beshansky; Harry P. Selker

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost Effectiveness of Thrombolytic Thera

✍ Mark, Daniel B.; Hlatky, Mark A.; Califf, Robert M.; Naylor, C. David; Lee, Kerr 📂 Article 📅 1995 🏛 Massachusetts Medical Society 🌐 English ⚖ 95 KB

Streptokinase, but not tissue plasminoge

✍ K.-E. KARLBERG; J. CHEN; I. HAGERMAN; K. BERGSTRÖM; R. WALLIN; T. SALDEEN; C. SY 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 589 KB

Thrombolysis with tissue plasminogen act

✍ Paassilta, M.; Kervinen, K.; Peuhkurinen, K.J.; Kesäniemi, Y.A. 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 652 KB

Temporal distribution of treatment to re

✍ Prediman K. Shah; Allan S. Lew; Bojan Cercek; William Ganz 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 187 KB

Efegatran sulfate as an adjunct to strep

✍ Anthony Y. Fung; Gerald Lorch; Patrick A. Cambier; Dennis Hansen; Bradley G. Tit 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 215 KB

An independently derived and validated p

✍ David M Kent; Rodney A Hayward; John L Griffith; Sandeep Vijan; Joni R Beshansky 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 117 KB